Little Green Pharma Ltd Stock

Equities

LGP

AU0000074924

Pharmaceuticals

Market Closed - Australian S.E. 02:10:13 2024-06-06 am EDT 5-day change 1st Jan Change
0.115 AUD -4.17% Intraday chart for Little Green Pharma Ltd -11.54% -17.86%
Sales 2025 * 29.8M 19.85M Sales 2026 * 35.5M 23.64M Capitalization 34.68M 23.1M
Net income 2025 * -3M -2M Net income 2026 * - 0 EV / Sales 2025 * 1.2 x
Net Debt 2025 * 1M 666K Net Debt 2026 * 700K 466K EV / Sales 2026 * 1 x
P/E ratio 2025 *
-11.5 x
P/E ratio 2026 *
-
Employees -
Yield 2025 *
-
Yield 2026 *
-
Free-Float 68.13%
More Fundamentals * Assessed data
Dynamic Chart
Little Green Pharma Ltd Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Little Green Pharma Welcomes Proposed Classification Downgrade of Cannabis in the US; Shares Rise 4% MT
EARNINGS AND TRADING: Chill Brands shareholder seeks board ejections AN
Little Green Pharma Posts Record AU$8.1 Million in Quarterly Cash Receipts, Up 50% on Previous Quarter MT
Little Green Pharma Ships First Shipment of High-THC Desert Flame Cannabis Flower Products to Poland; Shares Decline 9% MT
Transcript : Little Green Pharma Ltd - Shareholder/Analyst Call
Franchise Brands sets targets, Cindrigo agrees loan AN
Little Green Pharma Secures AU$5 Million R&D Tax Rebate in Fiscal Year 2023; Shares Rally 16% MT
Little Green Pharma's Psychedelics Subsidiary Opens Major Depressive Disorder Trial; Shares Fall 3% MT
Little Green Pharma Welcomes New Law for Supply of Medicinal Cannabis Oils in France; Shares Rise 4% MT
Transcript : Little Green Pharma Ltd, H1 2024 Pre Recorded Earnings Call, Nov 30, 2023
Little Green Pharma Ltd Reports Earnings Results for the Half Year Ended September 30, 2023 CI
PCI-PAL picked by Zoom; Biome in project delays AN
Tintra receives bid approach; NCC trading in line AN
Little Green Pharma Limited Announces Australian Clinical Study Finds Medicinal Cannabis Significantly Improves Pain, Quality of Life, Moderate-Severe Anxiety and Depression CI
More news

Latest transcript on Little Green Pharma Ltd

1 day-4.17%
1 week-11.54%
Current month-11.54%
1 month-11.54%
3 months-11.54%
6 months-8.00%
Current year-17.86%
More quotes
1 week
0.12
Extreme 0.115
0.13
1 month
0.12
Extreme 0.115
0.14
Current year
0.12
Extreme 0.115
0.16
1 year
0.12
Extreme 0.115
0.21
3 years
0.12
Extreme 0.115
0.97
5 years
0.12
Extreme 0.115
1.02
10 years
0.12
Extreme 0.115
1.02
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Founder - 17-05-28
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chairman 71 18-11-12
Director/Board Member - 18-11-12
Director/Board Member - 18-02-18
More insiders
Date Price Change Volume
24-06-06 0.115 -4.17% 80 374
24-06-05 0.12 -4.00% 297,063
24-06-04 0.125 +4.17% 178,600
24-06-03 0.12 -7.69% 99,254
24-05-31 0.13 +4.00% 16,152

Delayed Quote Australian S.E., June 06, 2024 at 02:10 am EDT

More quotes
Little Green Pharma Ltd is a global, vertically integrated and geographically diverse medicinal cannabis business with operations from cultivation and production through to manufacturing and distribution. The Company has two global production sites for the manufacture of its own-branded and white-label ranges of Good Manufacturing Practice (GMP)-grade medicinal cannabis products, being a 21,500 square meters cultivation and 4,000 square meters GMP manufacturing facility capable of producing over 30 tons of medicinal cannabis biomass per annum located in Denmark (EU) and an indoor cultivation and manufacturing facility located in Western Australia capable of producing three tons of medicinal cannabis biomass per annum. The Company focuses on patient access in the global medicinal cannabis market and is actively engaged in promoting education and outreach programs, as well as participating in clinical investigations and research projects to develop new delivery systems.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.12 AUD
Average target price
0.17 AUD
Spread / Average Target
+41.67%
Consensus

Annual profits - Rate of surprise